Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glenview Capital Management is a New York-based hedge fund founded by Larry Robbins in 2000. The firm manages several billion dollars across long/short equity and opportunistic strategies. It is particularly known for its focus on growth-at-a-reasonable-price (GARP) investing and has a strong track record of investing in cash-generative businesses with defensible market positions. Healthcare stocks are a major area of focus within its portfolio[1][3][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glenview Capital Management.